Home > Financial Ratios > KOPRAN

KOPRAN
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results

KOPRAN Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 62.27-44.02-1.77110.80-4.18

What is the latest Core EBITDA Growth ratio of KOPRAN ?

The latest Core EBITDA Growth ratio of KOPRAN is 62.27 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202462.27
Mar2023-44.02
Mar2022-1.77
Mar2021110.80
Mar2020-4.18

How is Core EBITDA Growth of KOPRAN Trending?

Years Core EBITDA Growth % Change
Mar2024 62.27
Positive
Mar2023 -44.02
Negative
Mar2022 -1.77
Negative
Mar2021 110.8
Positive
Mar2020 -4.18 -

Other Financial Ratios of KOPRAN


Compare Core EBITDA Growth ratio of peers of KOPRAN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KOPRAN ₹919.4 Cr 0.2% 7.4% -24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


KOPRAN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN

0.2%

7.4%

-24.5%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses